PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination

Journal of Controlled Release

Volumn 120, Issue 3, 2007, Pages 195-204

  Garinot, Marie ^a   Fiévez, Virginie ^a   Pourcelle, Vincent ^a   Stoffelbach, François ^b   des Rieux, Anne ^a   Plapied, Laurence ^a   Theate, Ivan ^c   Freichels, Hélène ^b   Jérôme, Christine ^b   Marchand Brynaert, Jacqueline ^a   Schneider, Yves Jacques ^a   Préat, Véronique ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

M cells targeting; Nanoparticles; Oral vaccination; RGD peptide

Indexed keywords

M CELLS TARGETING; ORAL VACCINATION; RGD PEPTIDE;

CELLS; GRAFTING (CHEMICAL); NANOPARTICLES; POLYETHYLENE GLYCOLS; VACCINES; ZETA POTENTIAL;

BIOMEDICAL ENGINEERING;

BETA1 INTEGRIN; CHOLERA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; MACROGOL 400; NANOPARTICLE; OVALBUMIN; POLYGLACTIN; VERY LATE ACTIVATION ANTIGEN 5;

ARTICLE; CANCER CELL CULTURE; CELL TRANSPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; COVALENT BOND; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MECHANISM; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INTERFERON PRODUCTION; INTESTINE CELL; M CELL; MOUSE; NONHUMAN; PEYER PATCH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; VACCINATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, CD29; CACO-2 CELLS; CELL LINE, TUMOR; COCULTURE TECHNIQUES; EPITHELIAL CELLS; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; IMMUNIZATION, SECONDARY; INJECTIONS, INTRAMUSCULAR; INTEGRIN ALPHA5BETA1; INTESTINAL MUCOSA; LACTIC ACID; MICE; MICE, INBRED STRAINS; NANOPARTICLES; OLIGOPEPTIDES; OVALBUMIN; OVARIAN FOLLICLE; PEYER'S PATCHES; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; POLYMERS; VACCINATION;

EID: 34447306055     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2007.04.021     Document Type: Article

References (38)

1. Mestecky J., Bienenstock J., Lamm M., Mayer L., McGhee J., and Strober W. Mucosal Immunity (2005), Elsevier academic Press
2. des Rieux A., Fievez V., Garinot M., Schneider Y.J., and Préat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J. Control. Release 116 (2006) 1-27
3. Brayden D.J., Jepson M.A., and Baird A.W. Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting. Drug Discov. Today 10 (2005) 1145-1157
4. Kraehenbuhl J.P., and Neutra M.R. Epithelial M cells: differentiation and function. Annu. Rev. Cell. Dev. Biol. 16 (2000) 301-332
5. Jang M.H., Kweon M.N., Watani K.I., Yamamoto M., Terahara K., Sasakawa C., Suzuki T., Nochi T., Yokota Y., Rennert P.D., Hiroi T., Tamagawa H., Iijima H., Kunisawa J., Yuki Y., and Kiyono H. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 6110-6115
6. Neutra M.R. Current concepts in mucosal immunity. V role of M cells in transepithelial transport of antigens and pathogens to the mucosal immune system. Am. J. Physiol. 274 (1998) G785-G791
7. Siebers A., and Finlay B.B. M cells and the pathogenesis of mucosal and systemic infections. Trends Microbiol. 4 (1996) 22-29
8. des Rieux A., Ragnarsson E.G.E., Gullberg E., Préat V., Schneider Y.J., and Artursson P. Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium. Eur. J. Pharm. Sci. 25 (2005) 455-465
9. Desai M.P., Labhasetwar V., Amidon G.L., and Levy R.J. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm. Res. 13 (1996) 1838-1845
10. Jung T., Kamm W., Breitenbach A., Hungerer K.D., Hundt E., and Kissel T. Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice. Pharm. Res. 18 (2001) 352-360
11. McClean S., Prosser E., Meehan E., O'Malley D., Clarke N., Ramtoola Z., and Brayden D. Binding and uptake of biodegradable poly-dl-lactide micro-and nanoparticles in intestinal epithelia. Eur. J. Pharm. Sci. 6 (1998) 153-163
12. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., and Langer R. Biodegradable long-circulating polymeric nanospheres. Science 263 (1994) 1600-1603
13. Nguyen C.A., Allemann E., Schwach G., Doelker E., and Gurny R. Cell interaction studies of PLA-MePEG nanoparticles. Int. J. Pharm. 254 (2003) 69-72
14. des Rieux A., Fievez V., Momtaz M., Detrembleur C., Alonso-Sande M., Van Gelder J., Cauvin A., Schneider Y.-J., and Préat V. Influence of M cells on oral delivery of helodermin. J. Control. Release 118 (2007) 294-302
15. Gullberg E., Leonard M., Karlsson J., Hopkins A.M., Brayden D., Baird A.W., and Artursson P. Expression of specific markers and particle transport in a new human intestinal M-cell model. Biochem. Biophys. Res. Commun. 279 (2000) 808-813
16. Gullberg E., Keita A.V., Salim S.Y., Andersson M., Caldwell K.D., Soderholm J.D., and Artursson P. Identification of cell adhesion molecules in the human follicle-associated epithelium that improve nanoparticle uptake into the Peyer's patches. J. Pharmacol. Exp. Ther. 319 (2006) 632-639
17. Kricheldorf H.R., Jonte J.M., and Berl M. Polylactones. 3. Copolymerization of glycolide with l,l-lactide and other lactones. Makromol. Chem. 12 (1985) 25-38
18. Cao L.W., Wang H., Li J.S., and Zhang H.S. 6-Oxy-(N-succinimidyl acetate)-9-(2′-methoxycarbonyl)fluorescein as a new fluorescent labeling reagent for aliphatic amines in environmental and food samples using high-performance liquid chromatography. J. Chromatogr. A. 1063 (2005) 143-151
19. Zweers M.L., Engbers G.H., Grijpma D.W., and Feijen J. In vitro degradation of nanoparticles prepared from polymers based on dl-lactide, glycolide and poly(ethylene oxide). J. Control. Release 100 (2004) 347-356
20. Vangeyte P., and Jérôme R. Amphiphilic block copolymers of high-molecular-weight poly(ethylene oxyde) and either ε-caprolactone or γ-methyl-ε-caprolactone: synthesis and characterization. J. Pharmacol. Exp. Ther. 42 (2004) 1132-1142
21. Vila A., Gill H., McCallion O., and Alonso M.J. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. J. Control. Release 98 (2004) 231-244
22. Means G.E., and Feeney R.E. Reductive alkylation of amino groups in proteins. Biochemistry 6 (1968) 2192-2201
23. Dressman J.B., and Reppas C. In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. Eur. J. Pharm. Sci. 11 (2000) S73-S80
24. Rescigno M., Urbano M., Valzasina B., Francolini M., Rotta G., Bonasio R., Granucci F., Kraehenbuhl J.P., and Ricciardi-Castagnoli P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2 (2001) 361-367
25. des Rieux A., Fievez V., Théate I., Mast J., Préat V., and Schneider Y.-J. An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells. Eur. J. Pharm. Sci. 30 (2007) 380-391
26. Artursson P. Epithelial transport of drugs in cell culture. I: a model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J. Pharm. Sci. 79 (1990) 476-482
27. Devouge S., Salvagnini C., and Marchand-Brynaert J. A practical molecular clip for immobilization of receptors and biomolecules on devices' surface: synthesis, grafting protocol and analytical assay. Bioorg. Med. Chem. Lett. 15 (2005) 3252-3256
28. Lombry C., Marteleur A., Arras M., Lison D., Louahed J., Renauld J.C., Preat V., and Vanbever R. Local and systemic immune responses to intratracheal instillation of antigen and DNA vaccines in mice. Pharm. Res. 21 (2004) 127-135
29. Foster N., Clark M.A., Jepson M.A., and Hirst B.H. Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo. Vaccine 16 (1998) 536-541
30. Schulte R., Kerneis S., Klinke S., Bartels H., Preger S., Kraehenbuhl J.P., Pringault E., and Autenrieth I.B. Translocation of Yersinia entrocolitica across reconstituted intestinal epithelial monolayers is triggered by Yersinia invasin binding to beta1 integrins apically expressed on M-like cells. Cell Microbiol. 2 (2000) 173-185
31. Belvisi L., Bernardi A., Colombo M., Manzoni L., Potenza D., Scolastico C., Giannini G., Marcellini M., Riccioni T., and Castorina M. Targeting integrins: Insights into structure and activity of cyclic RGD pentapeptide mimics containing azabicycloalkane amino acids. Bioorg. Med. Chem. 14 (2006) 169-180
32. C. Salvagnini, A. Roback, V. Pourcelle, M. Montaz, J. Marchand-Brynaert, Surface functionalization of poly(butylene terephtalate) melt blown filtration membrane by wet chemistry and photo-grafting, J. Biomater. Sci., Polym. (in press).
33. Pourcelle V., Devouge S., Garinot M., Préat V., and Marchand-Brynaert J. PCL-PEG-based nanoparticles grafted with GRGDS peptide: surface analysis. J. Colloid. Interface Sci. (2007)
34. Dong Y., and Feng S.S. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 25 (2004) 2843-2849
35. Eldridge J.H., Hammond C.J., Meulbroek J.A., Staas J.K., Gilley R.M., and Tice T.R. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J. Control. Release 11 (1990) 205-214
36. Shakweh M., Ponchel G., and Fattal E. Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery. Expert Opin. Drug Deliv. 1 (2004) 141-163
37. Prego C., Garcia M., Torres D., and Alonso M.J. Transmucosal macromolecular drug delivery. J. Control. Release 101 (2005) 151-162
38. Brayden D.J. Oral vaccination in man using antigens in particles: current status. Eur. J. Pharm. Sci. 14 (2001) 183-189